April 12, 2007 - The Medical Imaging & Technology Alliance (MITA), a division of NEMA, today released a report entitled "How Innovations in Medical Imaging Have Reduced Radiation Dosage," that indicates that innovations in imaging technologies lead to reductions of 20-75 percent in radiation dose for many imaging procedures.
The ability of medical imaging to provide physicians with this new information and new vision inside the human body has created dramatic improvements in the quality and length of lives. For example, CT has all but eliminated the practice of exploratory surgery with its associated invasive risks and lengthy recovery periods. These improvements have been widely documented in peer-reviewed medical journals, embodied in practice guidelines of medical specialty societies, and underscored by public and private regulatory agencies responsible for quality medical care.
Based upon an evaluation of the peer-reviewed literature that details the improvements brought about by such technologies as computed tomography (CT), nuclear medicine and X-ray radiography, it is reasonable to conclude that millions of lives have been saved and millions more dramatically improved as a result of these imaging technologies.

At the same time, this savings in lives and improvement in health outcomes occur--in the case of CT, X-ray, and nuclear medicine technology--as a result of the use of radiation. None of the health improvements that come from these technologies would be possible without radiation. The radiation exposure from such technologies for individual patients is in the low-range. Although the small potential risk of cancer from such levels of radiation is generally recognized, scientific studies have never conclusively linked the occurrence of cancer with the use of medical imaging technologies.

Manufacturers of medical imaging technology have introduced new product and system innovations during the past 20 years that have reduced radiation dose for many imaging procedures by 20-75 percent while preserving the ability of imaging technologies to aid physicians in diagnosing and treating disease. These dose reductions have been achieved through innovations in product operation and design, software applications, operating practices, and procedure algorithms. Among the reductions:

-"Pulsed" rather than continuous x-rays in minimally invasive surgical procedures reduce patient dose by 50-75 percent.
-Automated exposure controls that match the dose to body size and thickness reduce dose from 10-30 percent for routine CT examinations and, up to 50 percent for CT cardiac examinations.
-Reduced technique pediatric protocols that are based upon patient age and weight have reduced CT dose to pediatric patients significantly. Dose reductions of up to 80% for infants and 50 percent for small children are common with these pediatric protocols.

The full report is available at MITA's website, www.medicalimaging.org.

MITA an association of medical imaging and radiation therapy systems manufacturers and is a division of the National Electrical Manufacturers Association.


Related Content

News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now